[Should silent ischemia be diagnosed and treated?]

Area of Science:

• Cardiology
• Internal Medicine

Context:

• Silent myocardial ischemia is common in patients with ischemic heart disease, including those with angina pectoris or prior myocardial infarction.
• Diagnosis can be achieved through conventional exercise testing or ambulatory Holter monitoring.
• The underlying mechanisms causing symptomatic versus asymptomatic ischemia are not fully understood.

Purpose:

• To discuss the phenomenon of silent myocardial ischemia.
• To explore potential mechanisms behind symptomatic versus asymptomatic ischemia.
• To review the prognostic implications and treatment options for silent ischemia.

Summary:

• Silent myocardial ischemia, characterized by objective signs of ischemia without symptoms, is frequently observed in patients with ischemic heart disease.
• Both symptomatic and asymptomatic ischemia are associated with impaired left ventricular function, particularly reduced ejection fraction during exercise.
• Prognostic significance of silent ischemia varies across patient groups, and its impact on prognosis with current treatments is still under investigation.

Impact:

• Silent ischemia can be managed with antianginal medications or revascularization procedures.
• Further research is ongoing to determine if treating silent ischemia can improve patient outcomes.
• Understanding silent ischemia is crucial for risk stratification and management of patients with ischemic heart disease.